ClinVar Miner

Submissions for variant NM_000414.4(HSD17B4):c.1625G>A (p.Arg542Lys)

gnomAD frequency: 0.00001  dbSNP: rs546653967
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000728776 SCV000856390 uncertain significance not provided 2017-08-15 criteria provided, single submitter clinical testing
GeneDx RCV000728776 SCV000968899 likely benign not provided 2018-05-23 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Labcorp Genetics (formerly Invitae), Labcorp RCV001458298 SCV001662117 likely benign Bifunctional peroxisomal enzyme deficiency; Perrault syndrome 2024-01-17 criteria provided, single submitter clinical testing
Ambry Genetics RCV003353008 SCV004063480 likely benign Inborn genetic diseases 2023-07-25 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Revvity Omics, Revvity RCV000728776 SCV004235533 uncertain significance not provided 2023-11-09 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV004540039 SCV004790586 likely benign HSD17B4-related disorder 2023-04-11 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.